About
Technology
Issues
FAQ
Links
Official Page
Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advanced NSCLC
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.